Sweeping structural changes and scientific breakthroughs are driving
demand for new products, services and technologies
EndoGastric Solutions, Inc. is a medical device company and market leader in the emerging field of natural orifice translumenal endoscopic surgery, a new surgical approach that eliminates skin incisions in surgical operations on the stomach and gastrointestinal tract. The company’s endoscopic surgical devices enable incisionless, transoral procedures for the treatment of upper gastrointestinal problems, including gastroesophageal reflux disease and revision to bariatric surgery.
Tactile Systems Technology Inc. is a market leading medical device company dedicated to advancing the standard of care for at–home treatment of lymphedema, chronic edema, and non–healing venous ulcers. Tactile’s Flexitouch system is an innovative, patented medical device that simulates the gold-standard Manual Lymphatic Massage in cycle speed and pressure levels and effectively brings clinic based treatment into the patient’ home.
BEI Medical Systems Company, Inc. was acquired by Boston Scientific Corporation in June 2002. Prior to the acquisition, the company was engaged in the manufacture and marketing of a new, proprietary and minimally invasive endometrial ablation system, the Hydro ThermAblator HTA), representing a major advance in the treatment of abnormal uterine bleeding, a condition known as menorrhagia, that affects more than 10 million women in the U.S. annually. The HTA system received FDA approval and was commercially launched in 2001.
Bio-Lok International, Inc. was acquired by Healthpoint Capital in October 2006. Prior to the acquisition, the company was engaged in the manufacturing and distribution of an innovative line of dental implants and other products targeting the global oral surgery and general dentistry markets. Bio-Lok's industry-leading and FDA approved dental implant system, the Silhouette Laser-Lok™, utilizes a proprietary, laser micro-machined surface the Bio-Affinity Collar) to promote soft tissue and bone adherence while preventing epithelial down-growth - major advancements in the field of esthetic dentistry.
Conor Medsystems, Inc. was acquired by Johnson & Johnson in January 2007. Prior to the acquisition, Conor was developing, manufacturing and marketing next generation drug eluting stents. The company's initial focus was on the treatment of coronary restenosis. Conor completed an IPO in December 2004.
Heartscape Technologies, Inc. was acquired by Roper Industries, Inc. pursuant to an asset transaction in February 2010. Prior to the acquisition, the company was engaged in the manufacture, design and commercialization of the Prime ECG System, an 80-lead ECG developed for accurate early detection of heart attack and ischemia in the emergency room setting.
Medingo Ltd. was acquired by F. Hoffman La-Roche in 2010. Prior to the acquisition, Medingo was developing next generation insulin dispensing and glucose monitoring technologies for patients with diabetes. Medingo’s initial product, The Solo™, is one of the first products in a new category of insulin pumps called "dispensing patches" that will address the shortcomings of traditional larger "pager-like" pumps.
U-Systems, Inc. designs, develops, manufactures and markets innovative, ultrasound systems and software to assist the radiologist in detection of breast cancer in women with dense breast tissue. The Company's first product, the Somo.v™ automatically scans the whole-breast and presents the results to the physician in a mammogram-like format - enabling high volume, cost-effective ultrasound imaging.